Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and...

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in...

Disposition of Common Shares of Small Pharma Inc.

GH Research Provides Updates and Guidance on its Clinical Development Program...

PT446 – Decolonization, Interconnection, and the Medicalization of Mysticism

Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT...

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY...

So, You’ve Become a Psychedelic-Informed Practitioner. Now what?

Load more